Author

Lars Tharun

Observed names: L Tharun, L. Tharun, LARS THARUN, Tharun, Lars

Institutions: Humboldt-Universität zu Berlin, Institut für Hämatopathologie Hamburg, University Hospital Schleswig-Holstein, Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin

Observed institutions: University of Liège, Universität Hamburg, University of Cologne, University Hospital Heidelberg, Humboldt-Universität zu Berlin, Institut für Hämatopathologie Hamburg, University Medical Center Hamburg-Eppendorf, University Hospital Schleswig-Holstein, Medizinisches Versorgungszentrum Prof. Mathey, Prof. Schofer, Research Center Borstel - Leibniz Lung Center, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, University Hospital Cologne, Charité – Universitätsmedizin Berlin, University of Lübeck

ORCID: 0000-0001-7375-0775

Observed ORCID: 0000-0001-7375-0775

OpenAlex ID: A5078125633

Codon-specific translation reprogramming promotes resistance to targeted therapy

2018 · Francesca Rapino, Sylvain Delaunay, et al. · Nature · 283

HER-2 amplification is highly homogenous in gastric cancer

2009 · Andreas H. Marx, Lars Tharun, et al. · Human Pathology · 205

Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer

2016 · Sylvain Delaunay, Francesca Rapino, et al. · The Journal of Experimental Medicine · 183

PDF

Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial

2023 · Maarten Korrel, Leia R. Jones, et al. · The Lancet Regional Health - Europe · 152

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma

2017 · Axel Lechner, Hans Schlößer, et al. · Oncotarget · 133

PDF

A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer

2015 · Felix Dietlein, Bastian Kalb, et al. · Cell · 126

Elp3 drives Wnt-dependent tumor initiation and regeneration in the intestine

2015 · Aurélie Ladang, Francesca Rapino, et al. · The Journal of Experimental Medicine · 94

PDF

Recurrent HNSCC Harbor an Immunosuppressive Tumor Immune Microenvironment Suggesting Successful Tumor Immune Evasion

2020 · Christian Watermann, Helen Pasternack, et al. · Clinical Cancer Research · 86

PDF

Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases

2017 · Christian Koelsche, Daniel Schrimpf, et al. · Clinical Sarcoma Research · 75

PDF

Frequency of TERT promoter mutations in primary tumors of the liver

2014 · Alexander Quaas, Theresa Oldopp, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 74

The X-linked trichothiodystrophy-causing gene RNF113A links the spliceosome to cell survival upon DNA damage

2020 · Kateryna Shostak, Zheshen Jiang, et al. · Nature Communications · 55

PDF

STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs

2016 · Barbara Walch-Rückheim, Jennifer Pahne-Zeppenfeld, et al. · Cancer Research · 46

The Endosomal Protein CEMIP Links WNT Signaling to MEK1–ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids

2018 · Hong Quan Duong, Ivan Nemazanyy, et al. · Cancer Research · 44

PDF

Synergistic anti-angiogenic treatment effects by dual FGFR1 and VEGFR1 inhibition in FGFR1-amplified breast cancer

2018 · Kristina Golfmann, Lydia Meder, et al. · Oncogene · 40

Machine learning methods for automated classification of tumors with papillary thyroid carcinoma-like nuclei: A quantitative analysis

2021 · Moritz Böhland, Lars Tharun, et al. · PLoS ONE · 39

PDF

Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer

2009 · Matthias Choschzick, Annette Lebeau, et al. · Human Pathology · 35

Impact of stratified resection margin classification on local tumor control and survival in patients with oral squamous cell carcinoma

2021 · Samer G. Hakim, Robert von Bialy, et al. · Journal of Surgical Oncology · 32

PDF

The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression

2018 · Alessandro Torgovnick, Jan Michel Heger, et al. · Cell Reports · 28

PDF

Prognostic impact of perineural, blood and lymph vessel invasion for esophageal cancer.

2014 · Michael Tachezy, Anne-Kathrin Tiebel, et al. · PubMed · 28

Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma

2021 · Niklas Gebauer, Hanno M. Witte, et al. · Blood Advances · 25

TRIM24 as an independent prognostic biomarker for prostate cancer

2019 · Anne Offermann, Doris Roth, et al. · Urologic Oncology Seminars and Original Investigations · 24

Prospective study of computer-aided detection of colorectal adenomas in hospitalized patients

2023 · Carsten Engelke, Mattis Graf, et al. · Scandinavian Journal of Gastroenterology · 17

Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer

2022 · Anne Offermann, Vincent Joerg, et al. · American Journal Of Pathology · 17

Minimally Invasive vs Open Left Pancreatectomy for Resectable Pancreatic Cancer

2025 · Caro L. Bruna, Jony van Hilst, et al. · JAMA Surgery · 15

Histomorphological analysis of false positive PI-RADS 4 and 5 lesions

2020 · Marie Christine Hupe, Anne Offermann, et al. · Urologic Oncology Seminars and Original Investigations · 14

Works count: 96

Citation count: 2,052

H-index: 21

I10-index: 32